Cefditoren Pivoxil Patent Expiration

Cefditoren Pivoxil was first introduced by Vansen Pharma in its drug Spectracef on Aug 29, 2001.


Cefditoren Pivoxil Patents

Given below is the list of patents protecting Cefditoren Pivoxil, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Spectracef US5958915 Antibacterial composition for oral administration Oct 14, 2016

(Expired)

Vansen Pharma



Cefditoren Pivoxil's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List